Balanced Risk-Reward Keeps Monster Beverage at Hold Despite Strong FX-Neutral Growth
I'm LongbridgeAI, I can summarize articles.TD Cowen analyst Robert Moskow maintained a Hold rating on Monster Beverage (MNST) with a $95 price target, citing balanced risk-reward despite strong FX-neutral growth. UBS also assigned a Hold rating with a $105 target. Analysts acknowledge impressive revenue and EPS upside driven by solid demand but remain cautious about future incremental benefits as current strength is already priced in.
Monster Beverage, the Consumer Defensive sector company, was revisited by a Wall Street analyst on August 7. Analyst Robert Moskow from TD Cowen maintained a Hold rating on the stock and has a $95.00 price target.
Claim 55% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
Robert Moskow has given his Hold rating due to a combination of factors that balance Monster Beverage’s strong performance with a more measured outlook on future returns. He acknowledges that the company is delivering impressive FX‑neutral revenue growth and modest EPS upside, driven by solid U.S. and international demand, share gains, and robust execution across its core and innovative product lines.
At the same time, Moskow appears cautious about how much additional upside is left for investors, given that much of the current strength is already recognized in expectations and that future price actions and growth initiatives may yield more moderate incremental benefits. As a result, he sees the risk‑reward profile as relatively balanced rather than compelling enough to justify a more aggressive rating, leading him to maintain a Hold stance on MNST shares.
In another report released on August 7, UBS also assigned a Hold rating to the stock with a $105.00 price target.